St. Joseph's Healthcare Hamilton is a 777-bed academic health science centre in Hamilton, Ontario, Canada that is affiliated with the Michael G. DeGroote School of Medicine of McMaster University as well as Mohawk College.

There are 777 beds in St. Joseph's Healthcare Hamilton.

During the past decade, St. Joseph's Healthcare Hamilton conducted 209 clinical trials. In the 10-year time frame, 209 clinical trials started and 41 clinical trials were completed, i.e. on average, 19.6% percent of trials that started reached the finish line to date. In the past 5 years, 100 clinical trials started and 24 clinical trials were completed. i.e. 24% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Joseph's Healthcare Hamilton" #1 sponsor was "McMaster University" with 102 trials, followed by "St. Joseph's Healthcare Hamilton" with 65 trials sponsored, "Hamilton Health Sciences Corporation" with 25 trials sponsored, "Population Health Research Institute" with 13 trials sponsored and "University of Pennsylvania" with 13 trials sponsored. Other sponsors include 155 different institutions and companies that sponsored additional 100 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Joseph's Healthcare Hamilton" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 53 trials as a collaborator, "St. Joseph's Healthcare Hamilton" with 37 trials as a collaborator, "McMaster University" with 30 trials as a collaborator, "Hamilton Health Sciences Corporation" with 21 trials as a collaborator and "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 12 trials as a collaborator. Other collaborators include 329 different institutions and companies that were collaborators in the rest 209 trials.

According to Clinical.Site data, the most researched conditions in "St. Joseph's Healthcare Hamilton" are "Deep Vein Thrombosis" (12 trials), "Pulmonary Embolism" (12 trials), "Venous Thromboembolism" (12 trials), "Atrial Fibrillation" (10 trials) and "Critically Ill" (9 trials). Many other conditions were trialed in "St. Joseph's Healthcare Hamilton" in a lesser frequency.

Most popular intervention types in "St. Joseph's Healthcare Hamilton" are "Drug" (148 trials), "Other" (76 trials), "Procedure" (58 trials), "Device" (34 trials) and "Behavioral" (28 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (47 trials), "Nintedanib" (6 trials), "Once daily screening" (4 trials), "Pirfenidone" (4 trials) and "placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "St. Joseph's Healthcare Hamilton" are 347 trials for "All" genders, 26 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 93 active trials in "St. Joseph's Healthcare Hamilton". 8 are not yet recruiting, 66 are recruiting, 16 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 197 completed trials in St. Joseph's Healthcare Hamilton, 2 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in St. Joseph's Healthcare Hamilton, 10 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 22 trials, and there were also 127 trials that are defined as “Not Applicable".

St. Joseph's Healthcare Hamilton has several departments that took part in Clinical trials: "McMaster Institute of Urology" - 16 trials, "Margaret and Charles Juravinski Cancer Centre" - 55 trials, "St. Joseph's Healthcare Intensive Care Unit" - 3 trials